Dr. Richard Preston

Nephrology
Univ Of Miami-Division Of Pharmacology
1500 NW 12th Ave, 
Miami, FL 
Univ Of Miami-Division Of Pharmacology
1500 NW 12th Ave, 
Miami, FL 

Overview

Richard Preston is a Nephrologist practicing medicine in Miami, Florida.

His clinical expertise encompasses Chronic Kidney Disease and Menopause.

He is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 9 clinical trials.

Specialties

Nephrology

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

Univ of Miami-Division of Pharmacology
1500 NW 12th Ave, Miami, FL 33136

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 1, 2-Part, Open-Label, Single-Dose, Parallel Group Study to Determine the Effect of Hepatic Impairment on the Safety, Tolerability, and Pharmacokinetics of ACH-0144471 in Adult Subjects
A Phase 1, 2-Part, Open-Label, Single-Dose, Parallel Group Study to Determine the Effect of Hepatic Impairment on the Safety, Tolerability, and Pharmacokinetics of ACH-0144471 in Adult Subjects
Enrollment Status: Completed
Publish Date: August 20, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
Enrollment Status: Completed
Publish Date: June 30, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
Enrollment Status: Completed
Publish Date: April 13, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open Label, Multi-center, Parallel Cohort, Single Dose Study to Evaluate the Pharmacokinetics of LEE011 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function.
A Phase I, Open Label, Multi-center, Parallel Cohort, Single Dose Study to Evaluate the Pharmacokinetics of LEE011 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function.
Enrollment Status: Completed
Publish Date: December 19, 2020
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose Study to Investigate the Pharmacokinetics of Intravenous WCK 5222 (FEP-ZID) in Patients With Renal Impairment
A Phase 1, Open-label, Single-dose Study to Investigate the Pharmacokinetics of Intravenous WCK 5222 (FEP-ZID) in Patients With Renal Impairment
Enrollment Status: Completed
Publish Date: August 02, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

51 Total Publications

Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.
Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.
Journal: Journal of hypertension
Published: October 10, 2025
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required
5555 Ponce De Leon Boulevard, 
Coral Gables, FL 
 (6.9 miles away)
305-243-6251
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Alessia Fornoni is a Nephrologist practicing medicine in Coral Gables, Florida. Dr. Fornoni is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Nephropathy, Kidney Transplant, and Islet Cell Transplantation. Dr. Fornoni is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

University Of Miami Nephrology

1580 NW 10th Ave, 
Miami, FL 
 (0.2 miles away)
305-243-2349
Languages Spoken:
English
See accepted insurances

Jochen Reiser is a Nephrologist practicing medicine in Miami, Florida. Dr. Reiser is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Focal Segmental Glomerulosclerosis, Glomerulonephritis, Minimal Change Disease, Nephrotic Syndrome, and Kidney Transplant.

Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

Office

835 SW 37th Ave, 
Miami, FL 
 (3.3 miles away)
305-648-1087
Languages Spoken:
English
See accepted insurances

Juan Fernandez is a Nephrologist practicing medicine in Miami, Florida. Dr. Fernandez is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Schindler Disease, Fucosidosis, Beta-Mannosidosis, Alpha Mannosidosis, and Gastrostomy.

Frequently Asked Questions about Dr. Richard Preston

How do I make an appointment with Dr. Richard Preston?

You can book an appointment with Dr. Richard Preston by calling their office at 305-243-5930. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard Preston a top-rated expert for Chronic Kidney Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard Preston is classified as an Experienced expert for Chronic Kidney Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard Preston specialize in?

While Dr. Richard Preston is a Nephrology, they have specific expertise in Chronic Kidney Disease, Menopause. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nephrology.

Does Dr. Richard Preston participate in research or clinical trials?

Yes. Dr. Richard Preston has published 51 articles and abstracts on conditions like Chronic Kidney Disease. You can view a list of Dr. Richard Preston's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard Preston accept my insurance?

Dr. Richard Preston accepts most major insurance plans, including Aetna and Florida Blue. We recommend calling the office directly at 305-243-5930 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Preston's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile